Clearstead Advisors’s LeMaitre Vascular LMAT Stock Holding History

Clearstead Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-82	Closed	-$7.56K	–	2265
2024 Q4	$7.56K	Buy	82 +4	+5%	+$385	﹤0.01%	1646
2024 Q3	$7.25K	Hold	78	–	–	﹤0.01%	1644
2024 Q2	$6.42K	Buy	78 +3	+4%	+$220	﹤0.01%	1644
2024 Q1	$5.72K	Buy	75 +39	+108%	+$2.41K	﹤0.01%	1158
2023 Q4	$2.04K	Buy	+36	New	+$1.89K	﹤0.01%	1281
2022 Q2	–	Sell	-38	Closed	-$2K	–	1372
2022 Q1	$2K	Buy	+38	New	+$1.7K	﹤0.01%	1209

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Clearstead Advisors's LMAT Position: Q1 2025 in Review

Clearstead Advisors sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 82 shares — an estimated $7.56K sold.

Clearstead Advisors first reported a position in LMAT in Q1 2022 and held it in 6 quarters. The position peaked at $7.56K in Q4 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

Clearstead Advisors reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
Clearstead Advisors sold 82 LeMaitre Vascular shares in Q1 2025, an estimated $7.56K.
Clearstead Advisors first reported a position in LeMaitre Vascular in Q1 2022 and held it in 6 quarters.
Clearstead Advisors's LeMaitre Vascular position peaked at $7.56K in Q4 2024.
288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Clearstead Advisors's 13F filing for Q1 2025, filed 13 May 2025.